Public Health | November 30, 2021
Covishield effectiveness during the second wave at 63 per cent
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The company will provide the technical and financial resources to support the study
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
These vaccine doses will be manufactured and stockpiled by the company from August-December 2021
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
